Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Moosmann

Showing results (21-30 of 57) with videos related to

Pageof 6
Sort By:
Human Immunology|February 27, 2007
Activated B cells mediate efficient expansion of rare antigen-specific T cellsCaroline Zentz, Martina Wiesner, Stephen Man, et al.
Vaccine|August 19, 2017
A synthetic human cytomegalovirus pp65-IE1 fusion antigen efficiently induces and expands virus specific T cellsEllen K Link, Christine Brandmüller, Yasemin Suezer, et al.
Plos One|March 1, 2018
Characterization and clinical enrichment of HLA-C*07:02-restricted Cytomegalovirus-specific CD8+ T cellsFabian Schlott, Dominik Steubl, Stefanie Ameres, et al.
Plos One|July 6, 2007
Immunodominance of lytic cycle antigens in Epstein-Barr virus-specific CD4+ T cell preparations for therapyDinesh Adhikary, Uta Behrends, Heike Boerschmann, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 7, 2008
Engineering antigen-specific primary human NK cells against HER-2 positive carcinomasAnna Kruschinski, Andreas Moosmann, Isabel Poschke, et al.
European Journal of Immunology|June 23, 2005
Selection of CMV-specific CD8+ and CD4+ T cells by mini-EBV-transformed B cell linesMartina Wiesner, Caroline Zentz, Markus H Hammer, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 27, 2009
Activated human gammadelta T cells as stimulators of specific CD8+ T-cell responses to subdominant Epstein Barr virus epitopes: potential for immunotherapy of cancerSilke Landmeier, Bianca Altvater, Sibylle Pscherer, et al.
Cancer Immunology, Immunotherapy : CII|March 28, 2007
Immune restoration in head and neck cancer patients after in vivo COX-2 inhibitionStephan Lang, Sanjay Tiwari, Michaela Andratschke, et al.
Journal of Virology|October 3, 2014
Expression of the human cytomegalovirus UL11 glycoprotein in viral infection and evaluation of its effect on virus-specific CD8 T cellsIldar Gabaev, Endrit Elbasani, Stefanie Ameres, et al.
Cancer Immunology, Immunotherapy : CII|January 29, 2018
Epstein-Barr virus strain heterogeneity impairs human T-cell immunityAna Cirac, Simon Stützle, Michael Dieckmeyer, et al.
Pageof 6

Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
Human Immunology|February 27, 2007
Activated B cells mediate efficient expansion of rare antigen-specific T cellsCaroline Zentz, Martina Wiesner, Stephen Man, et al.
Vaccine|August 19, 2017
A synthetic human cytomegalovirus pp65-IE1 fusion antigen efficiently induces and expands virus specific T cellsEllen K Link, Christine Brandmüller, Yasemin Suezer, et al.
Plos One|March 1, 2018
Characterization and clinical enrichment of HLA-C*07:02-restricted Cytomegalovirus-specific CD8+ T cellsFabian Schlott, Dominik Steubl, Stefanie Ameres, et al.
Plos One|July 6, 2007
Immunodominance of lytic cycle antigens in Epstein-Barr virus-specific CD4+ T cell preparations for therapyDinesh Adhikary, Uta Behrends, Heike Boerschmann, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 7, 2008
Engineering antigen-specific primary human NK cells against HER-2 positive carcinomasAnna Kruschinski, Andreas Moosmann, Isabel Poschke, et al.
European Journal of Immunology|June 23, 2005
Selection of CMV-specific CD8+ and CD4+ T cells by mini-EBV-transformed B cell linesMartina Wiesner, Caroline Zentz, Markus H Hammer, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 27, 2009
Activated human gammadelta T cells as stimulators of specific CD8+ T-cell responses to subdominant Epstein Barr virus epitopes: potential for immunotherapy of cancerSilke Landmeier, Bianca Altvater, Sibylle Pscherer, et al.
Cancer Immunology, Immunotherapy : CII|March 28, 2007
Immune restoration in head and neck cancer patients after in vivo COX-2 inhibitionStephan Lang, Sanjay Tiwari, Michaela Andratschke, et al.
Journal of Virology|October 3, 2014
Expression of the human cytomegalovirus UL11 glycoprotein in viral infection and evaluation of its effect on virus-specific CD8 T cellsIldar Gabaev, Endrit Elbasani, Stefanie Ameres, et al.
Cancer Immunology, Immunotherapy : CII|January 29, 2018
Epstein-Barr virus strain heterogeneity impairs human T-cell immunityAna Cirac, Simon Stützle, Michael Dieckmeyer, et al.
Pageof 6